Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.

Darefsky AS, King JT Jr, Dubrow R.

Cancer. 2012 Apr 15;118(8):2163-72. doi: 10.1002/cncr.26494. Epub 2011 Aug 31.

2.

Temozolomide for high grade glioma.

Hart MG, Garside R, Rogers G, Stein K, Grant R.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD007415. doi: 10.1002/14651858.CD007415.pub2. Review.

PMID:
23633341
3.

Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.

Zarnett OJ, Sahgal A, Gosio J, Perry J, Berger MS, Chang S, Das S.

JAMA Neurol. 2015 May;72(5):589-96. doi: 10.1001/jamaneurol.2014.3739. Review.

PMID:
25822375
4.

Temozolomide for high grade glioma.

Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007415. doi: 10.1002/14651858.CD007415. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD007415.

PMID:
18843749
5.

Temozolomide and other potential agents for the treatment of glioblastoma multiforme.

Nagasawa DT, Chow F, Yew A, Kim W, Cremer N, Yang I.

Neurosurg Clin N Am. 2012 Apr;23(2):307-22, ix. doi: 10.1016/j.nec.2012.01.007. Review.

PMID:
22440874
6.

Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas.

St-Coeur PD, Touaibia M, Cuperlovic-Culf M, Morin P Jr.

Genomics Proteomics Bioinformatics. 2013 Aug;11(4):199-206. doi: 10.1016/j.gpb.2013.04.003. Epub 2013 Jun 1. Review.

7.

Glioblastoma survival: has it improved? Evidence from population-based studies.

Woehrer A, Bauchet L, Barnholtz-Sloan JS.

Curr Opin Neurol. 2014 Dec;27(6):666-74. doi: 10.1097/WCO.0000000000000144. Review.

PMID:
25364955
8.

Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.

Sarganas G, Orzechowski HD, Klimpel A, Thomae M, Kauffmann W, Herbst H, Bronder E, Garbe E.

Neuro Oncol. 2012 May;14(5):541-6. doi: 10.1093/neuonc/nos056. Epub 2012 Mar 6. Review.

9.

Glioblastoma multiforme: enhancing survival and quality of life.

Davis ME, Stoiber AM.

Clin J Oncol Nurs. 2011 Jun;15(3):291-7. doi: 10.1188/11.CJON.291-297. Review.

PMID:
21624864
10.

Type 2 Diabetes Mellitus and Glioblastoma Multiforme-Assessing Risk and Survival: Results of a Large Retrospective Study and Systematic Review of the Literature.

Barami K, Lyon L, Conell C.

World Neurosurg. 2017 Oct;106:300-307. doi: 10.1016/j.wneu.2017.06.164. Epub 2017 Jul 8. Review.

PMID:
28698089

Supplemental Content

Support Center